Insider transactions

EDGAR

VolitionRx Limited

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–40 of 40

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-21 Filed 2026-10-23Batchelor Ann-Louise Officer: Group Chief Marketing Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—27,786Direct (D) No
F1, F2, F3
  • F1 On October 21, 2026, the reporting person was awarded 12,000 RSUs under the Issuer's 2026 Stock Incentive Plan. The RSUs vest in full on January 9, 2027 (the Vesting Date), subject to the reporting person's continued service through such date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
  • F2 An aggregate of 6,681 of the 7,100 previously reported RSUs awarded under the Issuer's 2024 Stock Incentive Plan will vest on the Vesting Date, subject to the Reporting Person's continued service through such date, and settle for shares of common stock equal to the number of RSUs that have vested. The remaining 419 previously reported RSUs will not vest and will be forfeited. Accordingly, the amount of securities beneficially owned directly in column 5 of Table 1 reflects the forfeiture.
  • F3 On April 28, 2026, the Issuer effected a one-for-20 reverse stock split of its issued and outstanding common stock and made proportionate retroactive adjustments to its outstanding equity awards to the extent required including with respect to then-outstanding RSUs (the Reverse Split). No fractional shares were issued in connection with the Reverse Split, and each holder who otherwise would have been entitled to receive a fractional share received one whole share of common stock in lieu of such fractional share. Accordingly, the amount of securities beneficially owned directly and indirectly in column 5 of Table 1 has been adjusted to reflect the impact of the Reverse Split.
Open filing 0001477932-26-006439 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Michel Gaetan Officer: Chief Operating Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)6080.2529
153.7632

Derived: shares × price per share. Exact value 153.7632.

12,232Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 1,137 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-005935 Read from the filing’s XML Dispute this row
2026-09-28 Filed 2026-09-30Forterre Gael Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2840.2529
71.8236

Derived: shares × price per share. Exact value 71.8236.

16,284Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 687 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-005936 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-19Rootsaert Rodney Gerard Officer: Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,9480.19
750.12

Derived: shares × price per share. Exact value 750.12.

273,993Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,400 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001490 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-19Forterre Gael Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,2510.19
997.69

Derived: shares × price per share. Exact value 997.69.

331,338Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,700 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001491 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-19Plummer Nicholas Officer: GC - Volition Diagnostics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)7,0030.19
1,330.57

Derived: shares × price per share. Exact value 1330.57.

407,267Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 14,900 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001489 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-19Micallef Jacob Vincent Officer: Chief Scientific Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,3100.19
1,008.9

Derived: shares × price per share. Exact value 1008.90.

572,179Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,800 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001488 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-03Forterre Gael Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,2830.213
486.279

Derived: shares × price per share. Exact value 486.279.

336,589Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 5,523 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001146 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-03Plummer Nicholas Officer: GC - Volition Diagnostics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,8670.213
1,249.671

Derived: shares × price per share. Exact value 1249.671.

414,270Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,483 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001145 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-03Rootsaert Rodney Gerard Officer: Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,3210.213
707.373

Derived: shares × price per share. Exact value 707.373.

277,941Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,908 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-001147 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Rootsaert Rodney Gerard Officer: Secretary
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)119,0000—281,262Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 119,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001100 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Plummer Nicholas Officer: GC - Volition Diagnostics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)187,0000—420,137Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 187,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001099 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Kway Jasmine Officer: CEO - Singapore Volition
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)173,0000—418,614Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 173,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001097 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Innes Guy Archibald Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)178,0000—1,252,967Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 178,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001095 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Nguyen Kim Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)178,0000—305,816Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 178,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001098 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Micallef Jacob Vincent Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)149,0000—577,489Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 149,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001096 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Forterre Gael Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)149,0000—338,872Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 149,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001105 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Rubin Ethel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)178,0000—252,948Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 178,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date.
Open filing 0001477932-26-001104 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Hughes Terig Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)202,0000—684,970Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 202,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001101 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Batchelor Ann-Louise Officer: Group Chief Marketing Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)142,0000—324,072Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 142,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been both earned and vested as of the vesting date.
Open filing 0001477932-26-001102 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-02-27Reynolds Cameron John Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)486,0000—3,115,547Direct (D) No
F1
  • F1 On February 26, 2026, the reporting person was awarded 486,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Open filing 0001477932-26-001103 Read from the filing’s XML Dispute this row
2026-02-01 Filed 2026-02-03Rootsaert Rodney Gerard Officer: Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,1960.285
910.86

Derived: shares × price per share. Exact value 910.860.

162,262Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,611 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-000606 Read from the filing’s XML Dispute this row
2026-02-01 Filed 2026-02-03Forterre Gael Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,0100.285
572.85

Derived: shares × price per share. Exact value 572.850.

189,872Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 4,863 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-000607 Read from the filing’s XML Dispute this row
2026-02-01 Filed 2026-02-03Plummer Nicholas Officer: GC - Volition Diagnostics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,6470.285
1,609.395

Derived: shares × price per share. Exact value 1609.395.

233,137Direct (D) No
F1
  • F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,015 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
Open filing 0001477932-26-000605 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Innes Guy Archibald Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—1,074,967Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000372 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Rubin Ethel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—74,948Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000373 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Kway Jasmine Officer: CEO - Singapore Volition
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)42,0000—245,614Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 140,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 42,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 14,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 98,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000358 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Nguyen Kim Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—127,816Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000359 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Hughes Terig Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)49,2000—482,970Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 164,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 49,200 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 16,400 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 114,800 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000366 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Barnes Phillip Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—67,368Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000365 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Plummer Nicholas Officer: GC - Volition Diagnostics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)44,7000—238,784Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 149,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 44,700 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 14,900 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 104,300 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000361 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Batchelor Ann-Louise Officer: Group Chief Marketing Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)33,9000—182,072Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 113,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 33,900 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,300 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 79,100 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000367 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23STILL TIMOTHY I Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)90,0000—1,625,458Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 300,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 90,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 30,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 210,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000368 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Micallef Jacob Vincent Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)35,4000—428,489Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 118,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 35,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 82,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000362 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Rootsaert Rodney Gerard Officer: Secretary
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)28,2000—165,458Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 94,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,200 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,400 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 65,800 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000363 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Butera Salvatore Thomas Officer: CEO - Volition Veterinary
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)53,4000—375,203Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 178,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 53,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 17,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 124,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000364 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Forterre Gael Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)38,1000—191,882Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 127,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 38,100 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 12,700 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 88,900 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000371 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Reynolds Cameron John Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)74,7000—2,629,547Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 249,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 74,700 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 24,900 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 174,300 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000370 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Henshall Mickie Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—44,206Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000360 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-23Colman Alan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,0000—257,364Direct (D) No
F1
  • F1 On March 17, 2025, the reporting person was awarded 40,000 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
Open filing 0001477932-26-000369 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–31 of 31

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Lagoda Investment Management, L.P. 1,669,686 SH430,779 dollarsHigher by 213,736 Prior quarter: 1,455,950Open filing 0001493152-26-052428 Filed 2026-11-16 Dispute this row
LUMINUS MANAGEMENT LLC 425,372 SH109,746 dollarsHigher by 268,475 Prior quarter: 156,897Open filing 0001104659-26-128425 Filed 2026-11-16 Dispute this row
Quadrant Private Wealth Management, LLC 85,000 SH21,930 dollarsNot in the prior quarter’s filings read Open filing 0001725547-26-000393 Filed 2026-11-04 Dispute this row
Miller Financial Services LLC 71,000 SH18,318 dollarsNot in the prior quarter’s filings read Open filing 0002022893-26-000007 Filed 2026-10-20 Dispute this row
UBS Group AG Partly reported under another manager50,867 SH13,124 dollarsHigher by 46,448 Prior quarter: 4,419Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 50,684 SH13,076 dollarsUnchanged Prior quarter: 50,684Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager50,217 SH12,958 dollarsLower by 5,320 Prior quarter: 55,537Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Wealthspire Advisors, LLC 50,000 SH12,900 dollarsHigher by 5,000 Prior quarter: 45,000Open filing 0001646247-26-000006 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager47,656 SH12,295 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
STIFEL FINANCIAL CORP Partly reported under another manager45,050 SH11,623 dollarsNot in the prior quarter’s filings read Open filing 0000720672-26-000017 Filed 2026-11-12 Dispute this row
XTX Topco Ltd Partly reported under another manager35,347 SH9,120 dollarsHigher by 9,966 Prior quarter: 25,381Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager33,680 SH8,689 dollarsLower by 315 Prior quarter: 33,995Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 25,133 SH6,484 dollarsUnchanged Prior quarter: 25,133Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager19,087 SH4,925 dollarsLower by 3,221 Prior quarter: 22,308Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
StoneX Group Inc. Partly reported under another manager14,589 SH3,764 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
CITADEL ADVISORS LLC Option: Put Partly reported under another manager13,100 SH3,380 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager12,978 SH3,348 dollarsUnchanged Prior quarter: 12,978Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Silverberg Bernstein Capital Management LLC 10,636 SH2,744 dollarsLower by 1,884 Prior quarter: 12,520Open filing 0002007880-26-000006 Filed 2026-10-13 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager5,922 SH1,528 dollarsHigher by 154 Prior quarter: 5,768Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
SIMPLEX TRADING, LLC Option: Call 3,700 SH954 dollarsLower by 200 Prior quarter: 3,900Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1,999 SH516 dollarsUnchanged Prior quarter: 1,999Open filing 0001085146-26-000940 Filed 2026-11-13 Dispute this row
SIMPLEX TRADING, LLC Option: Put 1,900 SH490 dollarsHigher by 1,800 Prior quarter: 100Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
SBI Securities Co., Ltd. 750 SH194 dollarsHigher by 562 Prior quarter: 188Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
Hickory Point Bank Trust Partly reported under another manager250 SH65 dollarsNot in the prior quarter’s filings read Open filing 0002039144-26-000005 Filed 2026-10-01 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager150 SH39 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager31 SH8 dollarsUnchanged Prior quarter: 31Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager31 SH0 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager21 SH5 dollarsUnchanged Prior quarter: 21Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
GROUP ONE TRADING LLC 20 SH5 dollarsLower by 2,480 Prior quarter: 2,500Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager14 SH4 dollarsUnchanged Prior quarter: 14Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Caitong International Asset Management Co., Ltd 1 SH0 dollarsUnchanged Prior quarter: 1Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Squarepoint Ops LLC 10,685 SH
  • Arax Advisory Partners 5,552 SH
  • SIMPLEX TRADING, LLC 2,174 SH
  • Integrated Wealth Concepts LLC 1,000 SH
  • BARCLAYS PLC 357 SH
  • MERCER GLOBAL ADVISORS INC /ADV 7 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Lagoda Investment Management, L.P. Common Stock, par value $0.001 per share5.91,650,505.0009/15/2026 Filed 2026-09-16SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-042962 Dispute this row
Lagoda Investment Management, LLC Common Stock, par value $0.001 per share5.91,650,505.0009/15/2026 Filed 2026-09-16SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-042962 Dispute this row
Fatima Dickey Common Stock, par value $0.001 per share5.91,650,505.0009/15/2026 Filed 2026-09-16SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-042962 Dispute this row
Lagoda Investment Management, L.P. Common Stock, par value $0.001 per share7.41,652,005.0008/17/2026 Filed 2026-09-04SCHEDULE 13DOpen filing 0001493152-26-041611 Dispute this row
Lagoda Investment Management, LLC Common Stock, par value $0.001 per share7.41,652,005.0008/17/2026 Filed 2026-09-04SCHEDULE 13DOpen filing 0001493152-26-041611 Dispute this row
Fatima Dickey Common Stock, par value $0.001 per share7.41,652,005.0008/17/2026 Filed 2026-09-04SCHEDULE 13DOpen filing 0001493152-26-041611 Dispute this row
Lagoda Investment Management, L.P. Common Stock, par value $0.001 per share14.01,627,005.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 6Open filing 0001493152-26-038374 Dispute this row
Lagoda Investment Management, L.P. Common Stock, par value $0.001 per share10.717,070,103.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001493152-26-023734 Dispute this row
Lagoda Investment Management, L.P. Common Stock, par value $0.001 per share10.112,535,706.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 4Open filing 0001493152-26-007137 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.001 per share4.996,449,635.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 5Open filing 0001172661-26-001228 Dispute this row
Steven Boyd Common Stock, par value $0.001 per share4.996,449,635.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 5Open filing 0001172661-26-001228 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.001 per share8.729,380,425.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-005161 Dispute this row
Steven Boyd Common Stock, par value $0.001 per share8.729,380,425.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-005161 Dispute this row
Lagoda Investment Management, L.P. Common Stock, par value $0.001 per share11.311,705,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001641172-25-023996 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.001 per share9.999,804,352.0003/31/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-25-003624 Dispute this row
Steven Boyd Common Stock, par value $0.001 per share9.999,804,352.0003/31/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-25-003624 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,561,196 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020187,489
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to VolitionRx Limited